ConductScience.org, home

Paper2108212

Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

Schlesinger LS and 3 others. J Immunol, 1990. Cited by 397 papers, by iCite.

Cite this record

ConductScience Library. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. Papers, record 2108212. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2108212

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
PubMed
Journal
J Immunol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
397
iCite
Relative citation ratio, by iCite
9.6
iCite
Revised in PubMed
2014-11-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schlesinger LSL S
2Bellinger-Kawahara CGC G
3Payne NRN R
4Horwitz MAM A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C3Major topic
MonocytesMajor topic
Mycobacterium tuberculosisMajor topic
Receptors, ComplementMajor topic
Antibodies, Monoclonal
Bacterial Adhesion
Cells, Cultured
Complement Factor B
Complement Pathway, Alternative
Humans
In Vitro Techniques
Phagocytosis
Receptors, Fc

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AI-25681NIAID NIH HHSUnited StatesR01AI025681PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by219

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 397 citations.

PMIDTitleJournalYearIn PapersSource
42459678Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.Front Immunol2026https://conductscience.org/library/papers/42459678PubMed
42317732Mycobacterium tuberculosis subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.iScience2026https://conductscience.org/library/papers/42317732PubMed
41005755NR4A nuclear receptor expression in human macrophages mediates apoptosis and controls Mycobacterium tuberculosis growth.J Immunol2025https://conductscience.org/library/papers/41005755PubMed
40917351Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40917351PubMed
40787981Characterization of PPE19 as a novel mediator of Mycobacterium tuberculosis-macrophage interactions.mSphere2025https://conductscience.org/library/papers/40787981PubMed
40550843Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability.Commun Biol2025https://conductscience.org/library/papers/40550843PubMed
40241753CR1 variants contribute to FSGS susceptibility across multiple populations.iScience2025https://conductscience.org/library/papers/40241753PubMed
40214493Insights into Autophagy in Microbiome Therapeutic Approaches for Drug-Resistant Tuberculosis.Cells2025https://conductscience.org/library/papers/40214493PubMed
39499869Efficacy and Possible Mechanism(s) of Action of Gallium Tetraphenylporphyrin Nanoparticles against HIV-TB Coinfection in an In Vitro Granuloma Structure Model.ACS Infect Dis2024https://conductscience.org/library/papers/39499869PubMed
38184074HIV infection impairs the host response to Mycobacterium tuberculosis infection by altering surfactant protein D function in the human lung alveolar mucosa.Mucosal Immunol2024https://conductscience.org/library/papers/38184074PubMed
37864894Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis.Biomed Pharmacother2023https://conductscience.org/library/papers/37864894PubMed
37841265Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.Front Immunol2023https://conductscience.org/library/papers/37841265PubMed
37508391MCT-Dependent Cryptosporidium parvum-Induced Bovine Monocyte Extracellular Traps (METs) under Physioxia.Biology (Basel)2023https://conductscience.org/library/papers/37508391PubMed
37000865
Activation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling.
PLoS Pathog2023https://conductscience.org/library/papers/37000865PubMed
36882066Phagocytosis via complement receptor 3 enables microbes to evade killing by neutrophils.J Leukoc Biol2023https://conductscience.org/library/papers/36882066PubMed
36504842Correlates of vaccine protection against Mycobacterium avium sub-species paratuberculosis infection revealed in a transcriptomic study of responses in Gudair® vaccinated sheep.Front Vet Sci2022https://conductscience.org/library/papers/36504842PubMed
36085278Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteria.Nat Commun2022https://conductscience.org/library/papers/36085278PubMed
35935235Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study.Front Microbiol2022https://conductscience.org/library/papers/35935235PubMed
35736650Tuberculosis and Autoimmunity.Pathophysiology2022https://conductscience.org/library/papers/35736650PubMed
35012346Complement Receptor 3 Mediates HIV-1 Transcytosis across an Intact Cervical Epithelial Cell Barrier: New Insight into HIV Transmission in Women.mBio2022https://conductscience.org/library/papers/35012346PubMed

See all 219 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
CFB629PubTator's text mininghttps://conductscience.org/library/genes/629NCBI Gene
CR11378PubTator's text mininghttps://conductscience.org/library/genes/1378NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2108212

GET https://conductscience.org/api/papers/v1/2108212/cited_by?page=2